probably just late to the party zecs. Plenty of other gear is working well, they shouldn’t waste money on it. Had always thought the opportunity was in sepsis rather than specific to covid, and under all the rapid approvals that were going on it was an opportunity to get a covert sepsis trial going.
hope they can get apart of one of the trials, but definitely save our cash. Same goes for Pharmorage, spin it off IPO rather than do a CR for NOX, there is sufficient cash for the 4 pillars onc program should be seen through.
HIMR, page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.010(9.52%) |
Mkt cap ! $37.99M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 14.0¢ | 11.0¢ | $473.6K | 3.751M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 270001 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 153456 | 4 |
View Market Depth
| Last trade - 11.49am 03/09/2024 (20 minute delay) ? |
| NOX (ASX) Chart |